Bioorganic and Medicinal Chemistry Letters p. 339 - 344 (1996)
Update date:2022-08-03
Topics:
Xue
Rafalski
Roderick
Eyermann
Mousa
Olson
DeGrado
A potent centrally constrained series of benzimidazole and benzoxazole glycoprotein IIb/IIIa inhibitors has been discovered based on the solution conformation of a cyclic RGD-containing peptide, DMP 728. The high potency of this series of compounds in the inhibition of platelet aggregation requires a benzamidine as the basic moiety and an α-carbamate or sulfonamide substituted β-alanine as the acidic moiety.
View MoreHangzhou Showland Technology Co., Ltd.
Contact:86-571-88920516
Address:ROOM2118,NO.553,WENSAN ROAD,HANGZHOU,CHINA
Contact:+44 (0)2036089360-31
Address:Chanceryhouse,Chancery Lan
Shanghai AoBo Bio-Pharmaceutical Technology Co., Ltd.
Contact:+86-21-51320130-801, 816
Address:Room 601, No. 1011, Halei Road, Zhangjiang High-Tech Park, Pudong, Shanghai
Shanghai Dynamic Industrial Co.,Ltd.
website:http://www.shdynamic.com
Contact:86-021 3392 6680
Address:Room 805 Information Tower, No.1403 Minsheng Road, Pudong New Area, Shanghai 200135, P. R. China
Twin International Co., Limited
Contact:+86-21-80309280
Address:No.345 Jinxiang Road, Jinqiao Export Processing Zone
Doi:10.1016/0020-1693(95)90040-D
(1995)Doi:10.1023/A:1015054907007
(2002)Doi:10.1021/jo960008k
(1996)Doi:10.1023/A:1012374828303
(2001)Doi:10.1021/ic951550e
(1996)Doi:10.1016/0022-328X(95)05885-S
(1996)